
inglés
Tecnología y ciencia
$99 / mes después de la prueba.Cancela cuando quieras.
Acerca de JAMA Health Forum Conversations
JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses policies, structures, and systems that affect health, medicine, and health care. The journal publishes original research, evidence-based reports, and opinion about national and global health policy; structures and systems that affect health and health care; and health care delivery, economics, access, quality, safety, equity, and reform.
Keeping Health Equity at the Forefront of the AI Revolution
Artificial intelligence (AI) tools in health care and public health can bring efficiency and new approaches that might improve health. These tools may also have implications for health equity. Kevin Johnson, MD, MS, of the University of Pennsylvania joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to discuss the opportunities and challenges of AI in health care and public health. Related Content: * Keeping Health Equity at the Forefront of the Artificial Intelligence Revolution in Medicine and Health [https://jamanetwork.com/journals/jamahealthforum/fullarticle/10.1001/jamahealthforum.2025.6477?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Market-Based Solutions to Improve US Health Care
How do we better deploy market-based solutions to improve health care in the US? Lanhee Chen, PhD, of Stanford University joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to discuss how market-based approaches can complement public strategies to create a health care system that is more adaptive, responsive, and fiscally sustainable. Related Content: * A Role for Market Forces in US Health Care—Principles and Guardrails [https://jamanetwork.com/journals/jamahealthforum/fullarticle/10.1001/jamahealthforum.2025.6478?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
In Search of US Pharmaceutical Policy Innovation
Pharmaceuticals are a central—and costly—element of the US health care system. Aaron S. Kesselheim, MD, JD, MPH, of Brigham and Women's Hospital joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to discuss the challenge and opportunity of delivering affordable drugs to as many people as possible. Related Content: * In Search of Pharmaceutical Policy Innovation in the US [https://jamanetwork.com/journals/jamahealthforum/fullarticle/10.1001/jamahealthforum.2025.6049?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
The Future of Primary Care in the US
Historically, there has been less focus on primary care than on specialist care in US health care. What are the challenges and opportunities in primary care today? What might it look like in the coming decades? Robert Phillips, MD, MSPH, of The American Board of Family Medicine joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to discuss the future of primary care in the US. Related Content: * Back to the Future of Primary Care [https://jamanetwork.com/journals/jamahealthforum/fullarticle/10.1001/jamahealthforum.2025.5120?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Changes in Policy and the Health of LGBTQ+ Populations
There is abundant evidence that sexual minority groups have worse health indicators than sexual majority groups. Gilbert Gonzales, PhD, MHA, of Vanderbilt University Medical Center joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to discuss the current policy landscape and its potential impact on the health of LGBTQ+ populations. Related Content: * Health Implications of Recent Policy Changes Affecting LGBTQ+ Populations [https://jamanetwork.com/journals/jamahealthforum/fullarticle/10.1001/jamahealthforum.2025.4240?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Elige tu suscripción
Más populares
Premium
20 horas de audiolibros
Podcasts solo en Podimo
Disfruta los shows de Podimo sin anuncios
Cancela cuando quieras
Empieza 7 días de prueba
Después $99 / mes
Empieza 7 días de prueba. $99 / mes después de la prueba. Cancela cuando quieras.